Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community.
about
Vaccines for preventing pneumococcal infection in adultsInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseVaccines for preventing pneumococcal infection in adultsInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseAre the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trialsEffect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysisPneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or olderPneumococcal Vaccination Strategies. An Update and Perspective.Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.Efficacy of pneumococcal vaccination in adults: a meta-analysis.Current state of pneumococcal vaccines.Immunisation with a polyvalent pneumococcal vaccine. Effect of respiratory mortality in children living in the New Guinea highlands.Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia.Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.Pneumococcal serotypes in sputum isolates during acute respiratory illness in Edinburgh.Frequencies of pneumococcal types causing serious infections in patients admitted to the Radcliffe Infirmary, Oxford, 1969-77Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assayClinical effectiveness of pneumococcal vaccine. Meta-analysis.Analysing antibody response based on data obtained from serial dilution methods.Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.The late 1970s: a lull in the action on kuru.Pneumococcal polysaccharide vaccine: cost-effectiveness recommendations in adults.Australia's contribution to global immunisation.Adverse reactions to polyvalent pneumococcal vaccine.Antigenicity and protective effects of type 3 pneumococcal polysaccharide in ratsThe controversy over the efficacy of pneumococcal vaccine.Vaccination against pneumococcal disease.Triumphs and defeats in the control of infection by immunization.Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children.Efficacy of pneumococcal polysaccharide vaccine.Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study.
P2860
Q24201474-4D9D0610-EBAD-47FC-BB77-7A236FC85F5FQ24236699-6A83A916-5A41-4613-A688-A1E1468F0808Q24242290-67B8A5A4-FEEB-4066-AE8E-ADD1C0FE4A61Q24243866-5B25BAFF-CE50-4A8C-A6DA-DA98FC364E87Q24795536-C45A581B-59D6-4C12-8692-BA5B8AA3CDF8Q26801433-995D88A9-7311-4E00-8B7D-A190E2ABD73CQ28070059-BE4E74FF-33AC-452B-9518-3A4029D99878Q30238816-E66C520F-A910-45DD-A842-9E5C661D289FQ33542866-F76AD835-B13F-4789-AEF8-B0B4F7486168Q33772409-587EA82C-7274-461E-AAB1-0F133B470EA1Q34113328-81B7488A-AFB9-4C23-A763-E06821C0199DQ34657877-B9893004-F983-4F2F-B11F-7BF688F2C004Q34744239-C7DCB67F-2A0A-499A-904D-B6E04013BA62Q35115490-AA6D56F3-E85E-451A-82D8-042F0D5626C7Q35134469-179959CD-4E32-4909-9BF8-5D642340D585Q35533941-7F3E7CCC-7515-4D10-AB10-C3440B15F3D8Q36170421-665FBBC5-6146-4459-8BDD-02B77A0073D5Q36250716-B7263D35-F8AD-406C-B61F-B582A21B3514Q36257961-86CD4BDB-7EFA-4D05-B857-815907025CC6Q36454624-D273E5A7-89C7-4DCF-8BE3-F8D09B91ADA5Q36578027-FC25AB14-FF1E-4E10-9377-0125996041E9Q36601414-E47AB146-DD01-4399-AC64-A940CCC170A7Q37197138-C028F619-34BF-40A9-BCDA-EA94E939C739Q37327437-96136DDC-790A-405F-8EE6-FAECB0E858D5Q37609401-EEB5E80E-5434-4051-B494-7C4FE77710DDQ38065295-51C04101-2B98-4578-9CD2-17E4DB1E50B3Q40847841-7ACD9DB9-B6AC-45B5-B318-482D63862CB4Q41169399-89BCF379-B2FC-4FA3-BAA0-FCA0E56E21BAQ42075790-6D01368F-D08B-4F55-B5F3-4D63B9BCCCE9Q43216658-86C46391-05C5-4C6F-8FFB-B2D3EA4A0946Q45071299-6C7AF357-4F27-44B1-AB21-0057E41532D3Q46326360-D372A682-4D6B-4D99-94BD-60548E4FF44DQ46876874-050F6B11-4D2D-4C59-98D2-B8321E7956ECQ47711077-3ACC1826-BCC8-4354-AA15-BD037596CC02
P2860
Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Immunisation with a polyvalent ...... ew Guinea Highlands community.
@en
Immunisation with a polyvalent ...... ew Guinea Highlands community.
@nl
type
label
Immunisation with a polyvalent ...... ew Guinea Highlands community.
@en
Immunisation with a polyvalent ...... ew Guinea Highlands community.
@nl
prefLabel
Immunisation with a polyvalent ...... ew Guinea Highlands community.
@en
Immunisation with a polyvalent ...... ew Guinea Highlands community.
@nl
P2093
P1433
P1476
Immunisation with a polyvalent ...... ew Guinea Highlands community.
@en
P2093
G Jennison
M Pfeiffer
P Challands
P304
P356
10.1016/S0140-6736(77)92552-1
P407
P577
1977-06-01T00:00:00Z